Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

JINXIN TECHNOLOGY HOLDING CO (NAMI)

  • Business News
  • March 27, 2026, 11:05 UTC
  • 0
  • 1 comments

NamiBox Expands into AI Educational Companion Devices with NAMI COMPANION Series, Introducing a New Growth Vector in Smart Learning Hardware

Market reaction Comment Full text

SSR MINING INC. (SSRM)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

SSR Mining Announces Normal Course Issuer Bid

Market reaction Comment Full text

ADMA BIOLOGICS, INC. (ADMA)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 1
  • 1 comments

ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research

Market reaction Comment Full text

HONEYWELL INTERNATIONAL INC (HON)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

HONEYWELL ANNUAL SHAREOWNERS MEETING SET FOR MAY 22, 2026

Market reaction Comment Full text

LEGENCE CORP. (LGN)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

Legence Reports Fourth Quarter and Year End 2025 Financial Results

Market reaction Comment Full text

FORGENT POWER SOLUTIONS, INC. (FPS)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

Forgent Power Solutions Announces Pricing of Public Offering of Class A Common Stock

Market reaction Comment Full text

KANZHUN LTD (BZ)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 2
  • 1 comments

BOSS Zhipin Continued Share Repurchase, Total Repurchases Amount to Over RMB500 million in 2026

Market reaction Comment Full text

SATELLOS BIOSCIENCE INC. (MSLE)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

Satellos Reports 2025 Financial Results and Highlights Recent Company Progress

Market reaction Comment Full text

EDITAS MEDICINE, INC. (EDIT)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Market reaction Comment Full text

AUTOLUS THERAPEUTICS PLC (AUTL)

  • Business News
  • March 27, 2026, 11:00 UTC
  • 0
  • 1 comments

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Market reaction Comment Full text
  • Previous
  • 528
  • 529
  • 530
  • 531
  • 532
  • Next

Search

News categories

  • Technical Exchange News(11733)
  • Event(4112)
  • SEC News(232972)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(142386)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin